Recent Updates
Recently added Catalysts
XENE Positive Sentiment Score: 70/100

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Tuesday, May 7, 2024 1 min read
Key Takeaway: Xenon Pharmaceuticals Inc. announced its participation in the 2024 RBC Capital Markets Global Healthcare Conference scheduled for May 14-15, 2024, in New York. Company executives, including CEO Ian Mortimer and CFO Sherry Aulin, will present during the event. A live webcast of the presentation will be available on the company's website, offering broader accessibility to interested stakeholders. This engagement underscores Xenon's commitment to advancing neuroscience-focused therapeutics.

Market Sentiment Analysis

POSITIVE FACTORS

  • Xenon Pharmaceuticals is participating in a prominent healthcare conference, indicating strong industry presence.
  • The company's focus on neuroscience and innovative therapeutics addresses significant unmet medical needs.

Full Press Release Details

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY.
Fireside Chat Presentation Details:
Date: Tuesday, May 14, 2024
Time: 3:35 pm Eastern Time
Webcast: Register here
Presenters: Ian Mortimer, President and Chief Executive Officer Sherry Aulin, Chief Financial Officer
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Vice President, Investor Relations
investors@xenon-pharma.com
Xenon Corporate Affairs
media@xenon-pharma.com

Frequently Asked Questions

When is Xenon Pharmaceuticals presenting at the RBC Conference?

Xenon Pharmaceuticals will present at the RBC Capital Markets Conference on May 14, 2024.

Who will present for Xenon Pharmaceuticals at the event?

Ian Mortimer and Sherry Aulin will present for Xenon Pharmaceuticals.

What time is Xenon's presentation at the conference?

Xenon's presentation is scheduled for 3:35 PM Eastern Time.

Where can I watch the Xenon Pharmaceuticals presentation?

The presentation can be streamed live on Xenon's website in the Investors section.

What focus areas does Xenon Pharmaceuticals address?

Xenon focuses on developing therapies for neurological and psychiatric disorders.

Tags: XENE Viatris Investor Conferences Healthcare Xenon Pharmaceuticals RBC Capital Markets healthcare conference neuroscience biopharmaceuticals
Last updated: May 7, 2024